Iovance Biotherapeutics (IOVA)
Commercializes TIL cell therapies for melanoma and other solid-tumor settings.
$10.41
vs last close−0.23 (−2.21%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 63.31% | 286.79M shares | |
|---|---|---|---|
| 305 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.33% | 1.47M shares | |
| 9 holders · as of Sep 10, 2026 | |||
| Other | ≈ 36.36% | 164.70M shares | |
| remainder | |||
452.97M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
305 holders · 286.79M shares · 46 new positions · 175 increased · 66 reduced · 40 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 36.96M | 8.16% | +5.88M | Aug 7, 2026 |
| MHR Fund Management LLC | 28.97M | 6.39% | 0 | Aug 14, 2026 |
| State Street Corp | 24.48M | 5.40% | +7.03M | Aug 7, 2026 |
| Two Sigma Investments, LP | 19.01M | 4.20% | +5.32M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 18.20M | 4.02% | +1.59M | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 14.39M | 3.18% | +2.69M | Aug 13, 2026 |
| Geode Capital Management, LLC | 10.32M | 2.28% | +1.75M | Aug 12, 2026 |
| Millennium Management LLC | 8.53M | 1.88% | −888.4K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.40% | 21.31M | 13G | Jul 17, 2025 |
| State Street Corporation | 5.50% | 24.48M | 13G | Aug 7, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.